公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2011 | Gene targeting and expression analysis of mouse Tem1/endosialin using a lacZ reporter | HSIANG-PO HUANG ; Hong C.-L.; Kao C.-Y.; SHU-WHA LIN ; Lin S.-R.; Wu H.-L.; Shi G.-Y.; You L.-R.; Wu C.-L.; Yu I.-S. | Gene Expression Patterns | 25 | 19 | |
1996 | Gene therapy for hepatocellular carcinoma: Long-term remission of primary and metastatic tumors in mice by interleukin-2 gene therapy in vivo | HSIANG-PO HUANG ; Chen S.H.; Kosai K.; Finegold M.J.; Woo S.L.C. | Gene Therapy | 73 | 71 | |
2015 | Granulosa cell-derived induced pluripotent stem cells exhibit pro-Trophoblastic differentiation potential | Chuang C.-Y.; Huang M.-C.; HSIN-FU CHEN ; LI-HUI TSENG ; Yu C.-Y.; Stone L.; HSIANG-PO HUANG ; HONG-NERNG HO ; Kuo H.-C. | Stem Cell Research and Therapy | 11 | 9 | |
2019 | HAI-2 as a novel inhibitor of plasmin represses lung cancer cell invasion and metastasis | Wu S.-R.; Lin C.-H.; Shih H.-P.; Chun-Jung Ko ; Lin H.-Y.; Lan S.-W.; Lin H.-H.; Tu H.-F.; CHAO-CHI HO ; HSIANG-PO HUANG ; MING-SHYUE LEE | British Journal of Cancer | 8 | 9 | |
2014 | HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase | Tsai C.-H.; Teng C.-H.; Tu Y.-T.; Cheng T.-S.; Wu S.-R.; Chun-Jung Ko ; Shyu H.-Y.; Lan S.-W.; HSIANG-PO HUANG ; Tzeng S.-F.; Johnson M.D.; Lin C.-Y.; Hsiao P.-W.; MING-SHYUE LEE | Oncogene | 46 | 42 | |
2011 | Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification | HSIANG-PO HUANG ; Chen P.-H.; WUH-LIANG HWU ; Chuang C.-Y.; YIN-HSIU CHIEN ; Stone L.; CHUNG-LIANG CHIEN ; Li L.-T.; Chiang S.-C.; HSIN-FU CHEN ; HONG-NERNG HO ; Chen C.-H.; Kuo H.-C. | Human Molecular Genetics | 111 | 105 | |
2012 | Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification (vol 20, pg 4851, 2011) | HSIANG-PO HUANG ; Chen, PH; WUH-LIANG HWU; Chuang, CY; YIN-HSIU CHIEN ; Stone, L; CHUNG-LIANG CHIEN ; Li, LT; Chiang, SC; HSIN-FU CHEN ; HONG-NERNG HO ; Chen, CH; Kuo, HC | HUMAN MOLECULAR GENETICS | 0 | 0 | |
2012 | Induced pluripotent stem cell technology for disease modeling and drug screening with emphasis on lysosomal storage diseases | HSIANG-PO HUANG ; Chuang C.-Y.; Kuo H.-C. | Stem Cell Research and Therapy | 17 | 13 | |
2022 | An induced pluripotent stem cell-based model identifies molecular targets of vincristine neurotoxicity | Tsai, Neng-Wei; Lin, Cheng-Chen; Yeh, Ti-Yen; Chiu, Yu-An; Chiu, Hsin-Hui; HSIANG-PO HUANG ; SUNG-TSANG HSIEH | Disease models & mechanisms | 0 | 0 | |
2018 | Induced pluripotent stem cell-derived endothelial progenitor cells attenuate ischemic acute kidney injury and cardiac dysfunction | Shen W.-C.; YU-HSIANG CHOU ; HSIANG-PO HUANG ; Sheen J.-F.; Hung S.-C.; HSIN-FU CHEN | Stem Cell Research and Therapy | 27 | 27 | |
2017 | Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis | Chun-Jung Ko ; Lan S.-W.; YU-CHUAN LU ; Cheng T.-S.; Lai P.-F.; Tsai C.-H.; Hsu T.-W.; Lin H.-Y.; Shyu H.-Y.; Wu S.-R.; Lin H.-H.; Hsiao P.-W.; CHUNG-HSIN CHEN ; HSIANG-PO HUANG ; MING-SHYUE LEE | Oncogene | 38 | 32 | |
2020 | Inhibition of TMPRSS2 by HAI-2 reduces prostate cancer cell invasion and metastasis | Chun-Jung Ko ; Hsu, Ting-Wei; Wu, Shang-Ru; Lan, Shao-Wei; Hsiao, Ting-Feng; Lin, Hsin-Ying; Lin, Hsin-Hsien; Tu, Hsin-Fang; Lee, Cheng-Fan; Huang, Cheng-Chung; Chen, Mei-Ju May; Hsiao, Pei-Wen; HSIANG-PO HUANG ; MING-SHYUE LEE | Oncogene | 28 | 25 | |
2004 | Kawasaki disease associated with chickenpox: Report of two sibling cases | Lee D.-H.; HSIANG-PO HUANG | Acta Paediatrica Taiwanica | 15 | 0 | |
2017 | The Kunitz Domain i of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells | Wu S.-R.; Teng C.-H.; Tu Y.-T.; Chun-Jung Ko ; Cheng T.-S.; Lan S.-W.; Lin H.-Y.; Lin H.-H.; Tu H.-F.; Hsiao P.-W.; HSIANG-PO HUANG ; CHUNG-HSIN CHEN ; MING-SHYUE LEE | Scientific Reports | 15 | 12 | |
2010 | Matriptase is involved in ErbB-2-induced prostate cancer cell invasion | Wu S.-R.; Cheng T.-S.; Chen W.-C.; Shyu H.-Y.; Chun-Jung Ko ; HSIANG-PO HUANG ; Teng C.-H.; Lin C.-H.; Johnson M.D.; Lin C.-Y.; MING-SHYUE LEE | American Journal of Pathology | 34 | 31 | |
2022 | Matriptase-2/NR4A3 axis switches TGF-β action toward suppression of prostate cancer cell invasion, tumor growth, and metastasis | Lin, Hsin-Ying; Chun-Jung Ko ; Lo, Tzu-Yu; Wu, Shang-Ru; Lan, Shao-Wei; Huang, Chen-An; Lin, Yi-Chin; Lin, Hsin-Hsien; Tu, Hsin-Fang; Lee, Cheng-Fan; Hsiao, Pei-Wen; HSIANG-PO HUANG ; MEI-JOU CHEN ; Chang, Kai-Hsiung; MING-SHYUE LEE | Oncogene | 4 | 4 | |
2007 | Mice deficient in collapsin response mediator protein-1 exhibit impaired long-term potentiation and impaired spatial learning and memory | KANG-YI SU ; Chien W.-L.; WEN-MEI FU ; Yu I.-S.; HSIANG-PO HUANG ; PEI-HSIN HUANG ; Lin S.-R.; JIN-YUAN SHIH ; Lin Y.-L.; Hsueh Y.-P.; PAN-CHYR YANG ; SHU-WHA LIN | Journal of Neuroscience | 76 | 74 | |
2019 | Modeling spinocerebellar ataxias 2 and 3 with iPSCs reveals a role for glutamate in disease pathology | Chuang C.-Y.; Yang C.-C.; Soong B.-W.; Yu C.-Y.; Chen S.-H.; HSIANG-PO HUANG ; Kuo H.-C. | Scientific Reports | 26 | 24 | |
2002 | Neogenesis of β-cells in adult BETA2/NeuroD-deficient mice | HSIANG-PO HUANG ; Chu K.; Nemoz-Gaillard E.; Elberg D.; Tsai M.-J. | Molecular Endocrinology | 63 | 59 | |
2022 | Neuronal splicing regulator RBFOX3 mediates seizures via regulating Vamp1 expression preferentially in NPY-expressing GABAergic neurons | Huang, De-Fong; Lee, Chih-Yu; Chou, Ming-Yi; Yang, Tzu-Yin; Cao, Xuhui; Hsiao, Yu-Hsuan; Wu, Rui-Ni; Lien, Cheng-Chang; Huang, Yi-Shuian; HSIANG-PO HUANG ; SUSAN SHUR-FEN GAU ; HSIEN-SUNG HUANG | Proceedings of the National Academy of Sciences of the United States of America | 6 | 4 | |